Related Experiment Video
Updated: Oct 24, 2026

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α
Published on: November 2, 2018
Mitogen-activated protein kinase/ERK kinase kinases 2 and 3 activate nuclear factor-kappaB through IkappaB
1Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.
Abstract:
Recent evidence indicates that nuclear factor-kappaB (NF-kappaB), a transcription factor critically important for immune and inflammatory responses, is activated by a protein kinase cascade. The essential features of this cascade are that a mitogen-activated protein kinase kinase kinase (MAP3K) activates an IkappaB kinase (IKK) that site-specifically phosphorylates IkappaB. The IkappaB protein, which ordinarily sequesters NF-kappaB in the cytoplasm, is subsequently degraded by the ubiquitin-proteasome pathway, thereby allowing the nuclear translocation of NF-kappaB. Thus far, only two MAP3Ks, NIK and MEKK1, have been identified that can activate this pathway. We now show that MEKK2 and MEKK3 can in vivo activate IKK-alpha and IKK-beta, induce site-specific IkappaBalpha phosphorylation, and, relatively modestly, activate an NF-kappaB reporter gene. In addition, dominant negative versions of either IKK-alpha or IKK-beta abolish NF-kappaB activation induced by MEKK2 or MEKK3, thereby providing evidence that these IKKs mediate the NF-kappaB-inducing activities of these MEKKs. In contrast, other MAP3Ks, including MEKK4, ASK1, and MLK3, fail to show evidence of activation of the NF-kappaB pathway. We conclude that a distinct subset of MAP3Ks can activate NF-kappaB.
Insights
New research identifies MEKK2 and MEKK3 as activators of the nuclear factor-kappaB (NF-kappaB) pathway, crucial for immune responses. This finding expands our understanding of NF-kappaB regulation by specific mitogen-activated protein kinase kinase kinases (MAP3Ks).
Area of Science:
- Molecular Biology
- Immunology
- Cell Signaling
Background:
- Nuclear factor-kappaB (NF-kappaB) is a key transcription factor regulating immune and inflammatory processes.
- NF-kappaB activation involves a protein kinase cascade initiated by mitogen-activated protein kinase kinase kinases (MAP3Ks).
- Previously, only NIK and MEKK1 were known to activate this pathway.
Purpose of the Study:
- To investigate the role of MEKK2 and MEKK3 in activating the NF-kappaB signaling pathway.
- To determine if MEKK2 and MEKK3 can induce IkappaB phosphorylation and subsequent NF-kappaB activation.
Main Methods:
- In vivo experiments were conducted to assess the activation of IKK-alpha and IKK-beta by MEKK2 and MEKK3.
- Site-specific phosphorylation of IkappaBalpha was analyzed.
- NF-kappaB reporter gene activity was measured.
- Dominant-negative constructs of IKK-alpha and IKK-beta were used to confirm the role of these kinases.
Main Results:
- MEKK2 and MEKK3 were shown to activate IKK-alpha and IKK-beta in vivo.
- These MAP3Ks induced site-specific IkappaBalpha phosphorylation.
- MEKK2 and MEKK3 modestly activated an NF-kappaB reporter gene.
- Dominant-negative IKKs blocked NF-kappaB activation mediated by MEKK2 and MEKK3.
- Other MAP3Ks (MEKK4, ASK1, MLK3) did not activate the NF-kappaB pathway.
Conclusions:
- MEKK2 and MEKK3 represent a distinct subset of MAP3Ks capable of activating the NF-kappaB pathway.
- These findings elucidate a more comprehensive understanding of the upstream regulators of NF-kappaB signaling.
Related Concept Videos
MAPK Signaling Cascades
PI3K/mTOR/AKT Signaling Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Amplifying Signals via Enzymatic Cascade
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway
